Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Young Hoon Choi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2633-1401; OpenAlex author ID A5015486790. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: 3 papers · 2024: 1 paper · 2025: 2 papers

Papers 9

  1. Artificial Intelligence-Powered Spatial Analysis of Immune Phenotypes in Resected Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2025.1999↗
  2. Evaluation of Exosome-derived Small RNAs as Potential Biomarkers for Pancreatic Ductal Adenocarcinoma Using Next-generation Sequencing. Co-author DOI 10.3343/alm.2025.0121↗
  3. Characteristics of Early Pancreatic Cancer: Comparison between Stage 1A and Stage 1B Pancreatic Cancer in Multicenter Clinical Data Warehouse Study. First author DOI 10.3390/cancers16050944↗
  4. Lysosomal Storage Dysfunction, a Germline Variants Affecting Pancreatic Ductal Adenocarcinoma Development and Progression Co-author DOI 10.1101/2023.02.15.23286007↗
  5. Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12967-023-04549-x↗
  6. Lysosomal Storage Dysfunction, a Germline Variants Affecting Pancreatic Ductal Adenocarcinoma Development and Progression Co-author DOI 10.21203/rs.3.rs-2578124/v1↗
  7. Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. Co-author DOI 10.3390/biomedicines10061289↗
  8. Excision Repair Cross-Complementation Group 6 Gene Polymorphism Is Associated with the Response to FOLFIRINOX Chemotherapy in Asian Patients with Pancreatic Ca… Co-author DOI 10.3390/cancers13061196↗
  9. Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX. Co-author DOI 10.5009/gnl19182↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kyu Taek Lee · 5 shared papers, 2023–2025 · strength 0.82
  2. Joo Kyung Park · 5 shared papers, 2023–2025 · strength 0.82
  3. Jong Kyun Lee · 4 shared papers, 2023–2025 · strength 0.60
  4. Hye Min Kim · 4 shared papers, 2023–2025 · strength 0.60
  5. Kwang Hyuck Lee · 3 shared papers, 2023–2025 · strength 0.50
  6. Youngil Koh · 3 shared papers, 2023 · strength 0.42
  7. Hyung Rae Kim · 3 shared papers, 2023 · strength 0.42
  8. Sung‐Soo Yoon · 3 shared papers, 2023 · strength 0.42
  9. Daechan Park · 3 shared papers, 2023 · strength 0.42
  10. Jin Ho Choi · 2 shared papers, 2025 · strength 0.40
  11. In Seok Lee · 2 shared papers, 2022–2024 · strength 0.36
  12. Jin‐Young Jang · 2 shared papers, 2023 · strength 0.28
  13. Woo Hyun Paik · 2 shared papers, 2021 · strength 0.28
  14. Sang Hyub Lee · 2 shared papers, 2021 · strength 0.28
  15. Ji Kon Ryu · 2 shared papers, 2021 · strength 0.28
  16. Yong‐Tae Kim · 2 shared papers, 2021 · strength 0.28
  17. Jin‐Young Jang · 2 shared papers, 2021–2023 · strength 0.27
  18. Hyemin Kim · 1 shared paper, 2025 · strength 0.22
  19. Jong Kyun Lee · 1 shared paper, 2025 · strength 0.22
  20. Semin Lee · 1 shared paper, 2025 · strength 0.22
  21. Hyo Suk Kim · 1 shared paper, 2024 · strength 0.20
  22. Sung Woo Ko · 1 shared paper, 2024 · strength 0.20
  23. Jae Hyuck Chang · 1 shared paper, 2024 · strength 0.20
  24. So Jeong Yoon · 1 shared paper, 2025 · strength 0.18
  25. Jin Seok Heo · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.